Foresite Capital Management VI LLC
Foresite Capital Management VI LLC reported 22 holdings worth US$566M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Foresite Capital Management VI LLC reported 22 holdings worth US$566M as of Sep 30, 2026. Largest: CG Oncology, Inc., Latigo Biotherapeutics, Inc. and Seaport Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 22
- Value as reported
- US$566M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| CG Oncology, Inc. | 2.11M | US$150M | 26.4% |
| Latigo Biotherapeutics, Inc. | 2.2M | US$36.8M | 6.5% |
| Seaport Therapeutics, Inc. | 1.78M | US$35.9M | 6.3% |
| Denali Therapeutics Inc. | 1.62M | US$33.4M | 5.9% |
| Parabilis Medicines, Inc. | 999K | US$32.3M | 5.7% |
| Alumis Inc. | 4.25M | US$31.4M | 5.5% |
| Agios Pharmaceuticals, Inc. | 827K | US$27.5M | 4.9% |
| Verastem, Inc. | 3.15M | US$25.3M | 4.5% |
| Corvus Pharmaceuticals, Inc. | 1.83M | US$21.1M | 3.7% |
| Kymera Therapeutics, Inc. | 146K | US$16.4M | 2.9% |
| ArriVent BioPharma, Inc. | 490K | US$14.8M | 2.6% |
| Obsidian Therapeutics, Inc. | 916K | US$12.6M | 2.2% |
| Jade Biosciences, Inc. | 887K | US$12.5M | 2.2% |
| Hinge Health, Inc. | 108K | US$10.5M | 1.9% |
| Aura Biosciences, Inc. | 1.33M | US$8.37M | 1.5% |
| Beam Therapeutics Inc. | 330K | US$8.07M | 1.4% |
| Zura Bio Limited | 1.76M | US$7.31M | 1.3% |
| Minerva Neurosciences, Inc | 1.99M | US$6.65M | 1.2% |
| Disc Medicine, Inc. | 68,470 | US$4.48M | 0.79% |
| Kailera Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Research Alliance Corporation III | 0 | US$0 | 0.00% |
| AtaiBeckley Inc. | 0 | US$0 | 0.00% |
| Celldex Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Crinetics Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC